Rocky Mountain Cancer Centers (RMCC) ( Site 8006)

Denver, Colorado 80220

1 studies enrolling now · 1 studies all time

What they study most

Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms, Triple Negative Breast Neoplasms

Studies at this site

• A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) — Recruiting now